Delivery Order SPE2DB24D2205-SPE2DB25FEEYN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,704.98 firm-fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $14,704.98 and a performance period extending through June 3, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,352.49, is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm-fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a $14,704.98 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ERLEADA 240 MG TABLET UU 30S, with a period of performance through July 16, 2025. The contract is not set-aside and was awarded on June 24, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ERLEADA 60 MG TABLET UU 120S. The contract has a ceiling value of $21,918.84 and an ultimate completion date of August 29, 2024. It is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,676.34, is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of July 23, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $7,106.87 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564895304 - ERLEADA 60 MG TABLET UU 120S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 firm fixed-price delivery order is for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product, with a performance period through August 1, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ERLEADA 240 MG TABLET, a pharmaceutical product, with a ceiling value of $7,352.49 and a performance period through August 5, 2025. The contract is a Firm Fixed Price arrangement and is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for 120 units of the medication ERLEADA 60 MG TABLET, with a performance period ending on July 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEYNDelivery Order
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ERLEADA 240 MG TABLET UU 30S. The contract has a ceiling value of $7,352.49 and is a firm fixed price delivery order, with an ultimate completion date of August 6, 2025. This contract award is not a set-aside and was competitively awarded. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 7/16/25 |